Medicines

Thirty-sixth meeting of the Expert Committee on Drug Dependence


Agenda items 4.5-4.11

4. CRITICAL REVIEW OF PSYCHOACTIVE SUBSTANCES

Synthetic cannabinoids

4.5: (1-pentyl-1H -indol-3-yl)-1-naphthalenyl-methanone (JWH-018)@

4.6: (1-buty l- 1H-indol-3-yl)-1-naphthalenyl-methanone (JWH- 073)@

4.7: [1-(5-_fluoropentyl)-1H-indol-3-yl]-1-naphthalenyl-methanone (AM-2201)@

4.8: (1-pentyl-1H -indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (UR-144) @

4.9: 1-pentyl-N-tricyclo(3.3.1.13,7)dec-l-yl-1H-indazole-3-carboxamide (APINACA; AKB 48)@

4.10: (4-methoxyphenyl) (1-pentyl-1H -indol-3-yl)-methanone (RCS-4)@

4.11: 1-(1-pentyl-1H -indol-3-yl)-2-(2-methoxyphenyl)-ethanone (JWH-250)@

* Pre review recommendation @ CND resolution INCB request
Share